This MedLibrary.org supplementary page on Dexmedetomidine is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
|
Dexmedetomidine
|
|
| Systematic (IUPAC) name | |
| 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C13H16N2 |
| Mol. mass | 200.28 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 94% |
| Metabolism | near complete hepatic metabolism to inactive metabolites |
| Half life | 2 hours |
| Excretion | urinary |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | by intravenous infusion only |
Dexmedetomidine is a sedative medication used by intensive care units and anesthesiologists, and is marketed under the brand name Precedex (Hospira, Inc.) in the United States. It is relatively unique in its ability to provide sedation without causing respiratory depression. Like clonidine, its mechanism of action is agonism of alpha-2 receptors in certain parts of the brain.[1]
Dexmedetomidine has sedative, analgesic, sympatholytic, and anxiolytic effects that blunt many of the cardiovascular responses in the perioperative period. It reduces the volatile anesthetic, sedative and analgesic requirements of the patient without causing significant respiratory depression.[2]
Recent research has suggested dexmedetomidine to be an effective treatment for the dangerous cardiovascular symptoms of cocaine intoxication and overdose.[3] It also seemed to be superior to lorazepam for ventilated patients in the intensive care unit.[4]
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
References
- ^ Cormack JR, Orme RM, Costello TG. The role of alpha2-agonists in neurosurgery. Journal of Clinical Neuroscience. 2005 May;12(4):375-8.
- ^ Paris A, Tonner PH. Dexmedetomidine in anaesthesia. Current Opinion in Anaesthesiology. 2005 Aug;18(4):412-8.
- ^ Menon DV, Wang Z, Fadel PJ, Arbique D, Leonard D, Li JL, Victor RG, Vongpatanasin W. "Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans". J Am Coll Cardiol 2007; 50(7): 626-33. PMID 17692748
- ^ Pandharipande PP, Pun BT, Herr DL, et.al. "Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial." JAMA 2007; 298(22): 2644-53. PMID 18073360
|
|||||||||||||||||||||||||||||||||||||||
Wikipedia content modification information:
- This page was last modified on 8 August 2008, at 09:18.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Dexmedetomidine".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.